Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic laparoscopy with 5-aminolevulinic acid for peritoneal metastasis from colorectal cancer
jRCTs031200038Recruiting
- Sponsor
- National Center for Global Health and Medicine
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in peritoneal carcinomatosis (PC) and colorectal cancer (CRC), sponsored by National Center for Global Health and Medicine. Primary endpoint: Diagnostic sensitivity of ALA-PDD for peritoneal metastasis. Started May 2020; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
peritoneal carcinomatosis (PC)colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs031200038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200038.